All In MedTech

Device Trial Radar · NCT06138665

Evaluation of a New Noise Reduction Strategy in Hearing Aids

Last checked: Nov 19, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

17

Actual

Start

Nov 20, 2023

Primary completion

Mar 31, 2024

Study completion Mar 31, 2024

Sponsor

Lead sponsor
Sonova AGNot on our public-company list
Sponsor type
Industry
First posted
Nov 18, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this exploratory interventional study is to evaluate a new hearing aid noise-reduction strategy in experienced hearing aid users, compared to currently available strategies. The primary objective is to measure speech in noise performance with a new strategy and compare to the performance with currently available strategies via a coordinate response measure task.

Conditions

  • Hearing Loss

Interventions

  • Phonak Audeo Infinio SphereDevice

    Experimental device

  • Hearing aid BDevice

    Active comparator device from different manufacturer that is currently available

  • Hearing aid CDevice

    Active comparator device from different manufacturer that is currently available

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Coordinate Response MeasureTime frame: 1 day (lab visit 2)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Phonak Audiology Research Center

    Aurora, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.